Broadcom
AVGO
Micron Technology
MU
Adobe
ADBE
Salesforce
CRM
Qualcomm
QCOM
US Stock MarketDetailed Quotes
INBX Inhibrx Biosciences
- 13.890
- +0.010+0.07%
Trading Dec 20 15:43 ET
201.07MMarket Cap0.12P/E (TTM)
14.235High13.510Low65.50KVolume13.700Open13.880Pre Close898.04KTurnover0.86%Turnover RatioLossP/E (Static)14.48MShares18.95052wk High1.13P/B105.88MFloat Cap10.80052wk Low--Dividend TTM7.62MShs Float18.950Historical High--Div YieldTTM5.22%Amplitude10.800Historical Low13.709Avg Price1Lot Size
Inhibrx Biosciences Key Stats
EPS
According to the latest financial report of Inhibrx Biosciences, the latest earnings per share (TTM) for the company is -2.84. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Inhibrx Biosciences's free cash flow? The latest report shows it as -30.53M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Inhibrx Biosciences shows that the company's current ratio is 4.70, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Inhibrx Biosciences, the quick ratio is 4.48, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Inhibrx Biosciences? The latest ROE figure is -22.05%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Inhibrx Biosciences, the total asset return on investment (ROA) is -18.24%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Inhibrx Biosciences's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Inhibrx Biosciences, the net profit margin is 1.86M%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.